MRI-markers to Monitor Small Vessel Disease Dynamics in the Prognosis of Small Vessel Disease-associated, Cerebrovascular Events
Sponsored by Insel Gruppe AG, University Hospital Bern
About this trial
Last updated 2 years ago
Study ID
Status
Type
Placebo
Accepting
Trial Timing
Ended a year ago
What is this trial about?
What are the Participation Requirements?
For patients with intracerebral hemorrhage
Inclusion Criteria:
- Patient participating in the PRO-SVD cohort
- Symptomatic intracranial hemorrhage
- Written informed consent provided by patient or next-of-kin
- No contraindications against MRI
Exclusion Criteria:
- Patient unsuitable for MRI follow-ups (e.g. claustrophobia)
- Patients unlikely to attend 1-year follow-up
For healthy controls
Inclusion Criteria:
- Clinically healthy person ≥ 55 years
- Written informed consent provided by the healthy control
- No contraindications against MRI
Exclusion Criteria:
- Known or suspected cerebral small vessel diseases or presence of concurrent diseases
potentially mimicking small vessel disease (e.g. multiple sclerosis, previous heart
surgery etc.)
- Pre-existing dementia, cognitive decline or disorder of the central nervous system.